nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—SLC22A6—Methazolamide—glaucoma	0.0818	0.126	CbGbCtD
Nateglinide—CYP2D6—Carteolol—glaucoma	0.0671	0.103	CbGbCtD
Nateglinide—SLC22A6—Acetazolamide—glaucoma	0.0654	0.101	CbGbCtD
Nateglinide—CYP2D6—Betaxolol—glaucoma	0.0453	0.0698	CbGbCtD
Nateglinide—CYP2C9—Diclofenamide—glaucoma	0.0436	0.0672	CbGbCtD
Nateglinide—CYP2C9—Dorzolamide—glaucoma	0.0421	0.0649	CbGbCtD
Nateglinide—CYP3A5—Clonidine—glaucoma	0.0405	0.0624	CbGbCtD
Nateglinide—CYP2C9—Methazolamide—glaucoma	0.0376	0.0579	CbGbCtD
Nateglinide—CYP2D6—Methazolamide—glaucoma	0.0344	0.0529	CbGbCtD
Nateglinide—CYP3A4—Pilocarpine—glaucoma	0.0323	0.0498	CbGbCtD
Nateglinide—CYP2D6—Timolol—glaucoma	0.0292	0.045	CbGbCtD
Nateglinide—CYP3A4—Brinzolamide—glaucoma	0.0254	0.0391	CbGbCtD
Nateglinide—CYP2D6—Clonidine—glaucoma	0.0248	0.0383	CbGbCtD
Nateglinide—CYP3A4—Dorzolamide—glaucoma	0.0245	0.0377	CbGbCtD
Nateglinide—CYP3A4—Methazolamide—glaucoma	0.0218	0.0336	CbGbCtD
Nateglinide—CYP3A4—Acetazolamide—glaucoma	0.0175	0.0269	CbGbCtD
Nateglinide—CYP3A4—Clonidine—glaucoma	0.0158	0.0243	CbGbCtD
Nateglinide—Lisinopril—ACE2—glaucoma	0.00572	0.701	CrCbGaD
Nateglinide—Lacosamide—CA1—glaucoma	0.00139	0.17	CrCbGaD
Nateglinide—Hepatobiliary disease—Acetazolamide—glaucoma	0.00128	0.00492	CcSEcCtD
Nateglinide—Hyperhidrosis—Carbachol—glaucoma	0.00128	0.00491	CcSEcCtD
Nateglinide—Thirst—Clonidine—glaucoma	0.00128	0.0049	CcSEcCtD
Nateglinide—Bronchitis—Pilocarpine—glaucoma	0.00127	0.00486	CcSEcCtD
Nateglinide—Dyspepsia—Diclofenamide—glaucoma	0.00119	0.00458	CcSEcCtD
Nateglinide—Sweating—Dorzolamide—glaucoma	0.00119	0.00457	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00117	0.00449	CcSEcCtD
Nateglinide—Fatigue—Diclofenamide—glaucoma	0.00117	0.00449	CcSEcCtD
Nateglinide—Dyspepsia—Carbachol—glaucoma	0.00116	0.00447	CcSEcCtD
Nateglinide—Hepatobiliary disease—Brinzolamide—glaucoma	0.00115	0.00443	CcSEcCtD
Nateglinide—Injury—Betaxolol—glaucoma	0.00115	0.00442	CcSEcCtD
Nateglinide—Erythema multiforme—Acetazolamide—glaucoma	0.00115	0.00441	CcSEcCtD
Nateglinide—Increased appetite—Betaxolol—glaucoma	0.00113	0.00433	CcSEcCtD
Nateglinide—Sweating—Pilocarpine—glaucoma	0.00112	0.00432	CcSEcCtD
Nateglinide—Thirst—Betaxolol—glaucoma	0.00111	0.00427	CcSEcCtD
Nateglinide—Dyspepsia—Methazolamide—glaucoma	0.0011	0.00422	CcSEcCtD
Nateglinide—Hypersensitivity—Metipranolol—glaucoma	0.0011	0.00421	CcSEcCtD
Nateglinide—Hypoglycaemia—Betaxolol—glaucoma	0.00108	0.00416	CcSEcCtD
Nateglinide—Oedema peripheral—Brinzolamide—glaucoma	0.00108	0.00414	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methazolamide—glaucoma	0.00108	0.00414	CcSEcCtD
Nateglinide—Fatigue—Methazolamide—glaucoma	0.00108	0.00413	CcSEcCtD
Nateglinide—Asthenia—Metipranolol—glaucoma	0.00107	0.0041	CcSEcCtD
Nateglinide—Osteoarthritis—Betaxolol—glaucoma	0.00106	0.00406	CcSEcCtD
Nateglinide—Immune system disorder—Brimonidine—glaucoma	0.00105	0.00405	CcSEcCtD
Nateglinide—Erythema multiforme—Dorzolamide—glaucoma	0.00105	0.00405	CcSEcCtD
Nateglinide—Lacosamide—CA2—glaucoma	0.00105	0.129	CrCbGaD
Nateglinide—Abdominal pain—Carbachol—glaucoma	0.00105	0.00402	CcSEcCtD
Nateglinide—Palpitations—Apraclonidine—glaucoma	0.00105	0.00401	CcSEcCtD
Nateglinide—Oedema peripheral—Pilocarpine—glaucoma	0.00104	0.00398	CcSEcCtD
Nateglinide—Urticaria—Levobunolol—glaucoma	0.00103	0.00397	CcSEcCtD
Nateglinide—Hypersensitivity—Carteolol—glaucoma	0.00102	0.0039	CcSEcCtD
Nateglinide—Palpitations—Bimatoprost—glaucoma	0.00101	0.00389	CcSEcCtD
Nateglinide—Immune system disorder—Travoprost—glaucoma	0.001	0.00385	CcSEcCtD
Nateglinide—Cough—Bimatoprost—glaucoma	0.001	0.00384	CcSEcCtD
Nateglinide—Urticaria—Methazolamide—glaucoma	0.000992	0.00381	CcSEcCtD
Nateglinide—Immune system disorder—Brinzolamide—glaucoma	0.00099	0.0038	CcSEcCtD
Nateglinide—Asthenia—Carteolol—glaucoma	0.000989	0.0038	CcSEcCtD
Nateglinide—Dizziness—Metipranolol—glaucoma	0.000984	0.00378	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Clonidine—glaucoma	0.000977	0.00375	CcSEcCtD
Nateglinide—Asthenia—Diclofenamide—glaucoma	0.000973	0.00373	CcSEcCtD
Nateglinide—Hypersensitivity—Levobunolol—glaucoma	0.00096	0.00369	CcSEcCtD
Nateglinide—Pruritus—Diclofenamide—glaucoma	0.000959	0.00368	CcSEcCtD
Nateglinide—Malnutrition—Brinzolamide—glaucoma	0.000954	0.00366	CcSEcCtD
Nateglinide—Back pain—Dorzolamide—glaucoma	0.000939	0.0036	CcSEcCtD
Nateglinide—Rash—Metipranolol—glaucoma	0.000938	0.0036	CcSEcCtD
Nateglinide—Dermatitis—Metipranolol—glaucoma	0.000937	0.0036	CcSEcCtD
Nateglinide—Asthenia—Levobunolol—glaucoma	0.000935	0.00359	CcSEcCtD
Nateglinide—Back pain—Travoprost—glaucoma	0.000934	0.00359	CcSEcCtD
Nateglinide—Back pain—Brinzolamide—glaucoma	0.000923	0.00354	CcSEcCtD
Nateglinide—Pruritus—Levobunolol—glaucoma	0.000922	0.00354	CcSEcCtD
Nateglinide—Influenza—Betaxolol—glaucoma	0.000915	0.00351	CcSEcCtD
Nateglinide—Dizziness—Carteolol—glaucoma	0.000912	0.0035	CcSEcCtD
Nateglinide—Diarrhoea—Carbachol—glaucoma	0.000905	0.00348	CcSEcCtD
Nateglinide—Sweating—Clonidine—glaucoma	0.000898	0.00345	CcSEcCtD
Nateglinide—Palpitations—Brimonidine—glaucoma	0.000898	0.00345	CcSEcCtD
Nateglinide—Dizziness—Diclofenamide—glaucoma	0.000896	0.00344	CcSEcCtD
Nateglinide—Asthenia—Methazolamide—glaucoma	0.000895	0.00344	CcSEcCtD
Nateglinide—Tremor—Brinzolamide—glaucoma	0.000894	0.00343	CcSEcCtD
Nateglinide—Diarrhoea—Levobunolol—glaucoma	0.000891	0.00342	CcSEcCtD
Nateglinide—Back pain—Pilocarpine—glaucoma	0.000887	0.0034	CcSEcCtD
Nateglinide—Cough—Brimonidine—glaucoma	0.000887	0.0034	CcSEcCtD
Nateglinide—Hypoglycaemia—Timolol—glaucoma	0.000886	0.0034	CcSEcCtD
Nateglinide—Nausea—Metipranolol—glaucoma	0.000884	0.00339	CcSEcCtD
Nateglinide—Bronchitis—Betaxolol—glaucoma	0.00088	0.00338	CcSEcCtD
Nateglinide—Dizziness—Carbachol—glaucoma	0.000875	0.00336	CcSEcCtD
Nateglinide—Osteoarthritis—Timolol—glaucoma	0.000865	0.00332	CcSEcCtD
Nateglinide—Vomiting—Diclofenamide—glaucoma	0.000862	0.00331	CcSEcCtD
Nateglinide—Dizziness—Levobunolol—glaucoma	0.000862	0.00331	CcSEcCtD
Nateglinide—Tremor—Pilocarpine—glaucoma	0.000859	0.0033	CcSEcCtD
Nateglinide—Palpitations—Dorzolamide—glaucoma	0.000857	0.00329	CcSEcCtD
Nateglinide—Pruritus—Latanoprost—glaucoma	0.000855	0.00328	CcSEcCtD
Nateglinide—Rash—Diclofenamide—glaucoma	0.000855	0.00328	CcSEcCtD
Nateglinide—Diarrhoea—Methazolamide—glaucoma	0.000854	0.00328	CcSEcCtD
Nateglinide—Palpitations—Travoprost—glaucoma	0.000854	0.00328	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Betaxolol—glaucoma	0.00085	0.00326	CcSEcCtD
Nateglinide—Cough—Dorzolamide—glaucoma	0.000847	0.00325	CcSEcCtD
Nateglinide—Cough—Travoprost—glaucoma	0.000843	0.00324	CcSEcCtD
Nateglinide—Palpitations—Brinzolamide—glaucoma	0.000843	0.00324	CcSEcCtD
Nateglinide—Vomiting—Carbachol—glaucoma	0.000841	0.00323	CcSEcCtD
Nateglinide—Rash—Carbachol—glaucoma	0.000834	0.0032	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000834	0.0032	CcSEcCtD
Nateglinide—Dermatitis—Carbachol—glaucoma	0.000833	0.0032	CcSEcCtD
Nateglinide—Fatigue—Apraclonidine—glaucoma	0.000833	0.0032	CcSEcCtD
Nateglinide—Cough—Brinzolamide—glaucoma	0.000832	0.0032	CcSEcCtD
Nateglinide—Dyspepsia—Bimatoprost—glaucoma	0.000824	0.00316	CcSEcCtD
Nateglinide—Nausea—Carteolol—glaucoma	0.000819	0.00314	CcSEcCtD
Nateglinide—Palpitations—Pilocarpine—glaucoma	0.00081	0.00311	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000808	0.0031	CcSEcCtD
Nateglinide—Nausea—Diclofenamide—glaucoma	0.000805	0.00309	CcSEcCtD
Nateglinide—Cough—Pilocarpine—glaucoma	0.0008	0.00307	CcSEcCtD
Nateglinide—Neuropathy peripheral—Betaxolol—glaucoma	0.0008	0.00307	CcSEcCtD
Nateglinide—Dizziness—Latanoprost—glaucoma	0.000799	0.00307	CcSEcCtD
Nateglinide—Vomiting—Methazolamide—glaucoma	0.000794	0.00305	CcSEcCtD
Nateglinide—Gastrointestinal pain—Apraclonidine—glaucoma	0.00079	0.00303	CcSEcCtD
Nateglinide—Rash—Methazolamide—glaucoma	0.000787	0.00302	CcSEcCtD
Nateglinide—Dermatitis—Methazolamide—glaucoma	0.000786	0.00302	CcSEcCtD
Nateglinide—Nausea—Carbachol—glaucoma	0.000786	0.00302	CcSEcCtD
Nateglinide—Sweating—Betaxolol—glaucoma	0.000782	0.003	CcSEcCtD
Nateglinide—Nausea—Levobunolol—glaucoma	0.000774	0.00297	CcSEcCtD
Nateglinide—Hyperhidrosis—Dorzolamide—glaucoma	0.000766	0.00294	CcSEcCtD
Nateglinide—Abdominal pain—Apraclonidine—glaucoma	0.000764	0.00293	CcSEcCtD
Nateglinide—Rash—Latanoprost—glaucoma	0.000762	0.00292	CcSEcCtD
Nateglinide—Dermatitis—Latanoprost—glaucoma	0.000761	0.00292	CcSEcCtD
Nateglinide—Dyspepsia—Acetazolamide—glaucoma	0.00076	0.00292	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000746	0.00286	CcSEcCtD
Nateglinide—Fatigue—Acetazolamide—glaucoma	0.000745	0.00286	CcSEcCtD
Nateglinide—Nausea—Methazolamide—glaucoma	0.000741	0.00285	CcSEcCtD
Nateglinide—Dyspepsia—Brimonidine—glaucoma	0.00073	0.0028	CcSEcCtD
Nateglinide—Hyperhidrosis—Pilocarpine—glaucoma	0.000723	0.00278	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000716	0.00275	CcSEcCtD
Nateglinide—Fatigue—Brimonidine—glaucoma	0.000715	0.00274	CcSEcCtD
Nateglinide—Hypersensitivity—Apraclonidine—glaucoma	0.000712	0.00273	CcSEcCtD
Nateglinide—Dyspepsia—Dorzolamide—glaucoma	0.000697	0.00268	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Timolol—glaucoma	0.000695	0.00267	CcSEcCtD
Nateglinide—Dyspepsia—Travoprost—glaucoma	0.000694	0.00266	CcSEcCtD
Nateglinide—Asthenia—Apraclonidine—glaucoma	0.000693	0.00266	CcSEcCtD
Nateglinide—Urticaria—Acetazolamide—glaucoma	0.000686	0.00263	CcSEcCtD
Nateglinide—Tremor—Clonidine—glaucoma	0.000686	0.00263	CcSEcCtD
Nateglinide—Dyspepsia—Brinzolamide—glaucoma	0.000685	0.00263	CcSEcCtD
Nateglinide—Pruritus—Apraclonidine—glaucoma	0.000683	0.00262	CcSEcCtD
Nateglinide—Fatigue—Dorzolamide—glaucoma	0.000683	0.00262	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Travoprost—glaucoma	0.000681	0.00261	CcSEcCtD
Nateglinide—Fatigue—Travoprost—glaucoma	0.00068	0.00261	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000672	0.00258	CcSEcCtD
Nateglinide—Asthenia—Bimatoprost—glaucoma	0.000672	0.00258	CcSEcCtD
Nateglinide—Fatigue—Brinzolamide—glaucoma	0.000671	0.00258	CcSEcCtD
Nateglinide—Pruritus—Bimatoprost—glaucoma	0.000663	0.00254	CcSEcCtD
Nateglinide—Immune system disorder—Betaxolol—glaucoma	0.000661	0.00254	CcSEcCtD
Nateglinide—Diarrhoea—Apraclonidine—glaucoma	0.000661	0.00254	CcSEcCtD
Nateglinide—Dyspepsia—Pilocarpine—glaucoma	0.000659	0.00253	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000648	0.00249	CcSEcCtD
Nateglinide—Palpitations—Clonidine—glaucoma	0.000647	0.00248	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000646	0.00248	CcSEcCtD
Nateglinide—Gastrointestinal pain—Travoprost—glaucoma	0.000645	0.00248	CcSEcCtD
Nateglinide—Cough—Clonidine—glaucoma	0.000639	0.00245	CcSEcCtD
Nateglinide—Sweating—Timolol—glaucoma	0.000639	0.00245	CcSEcCtD
Nateglinide—Dizziness—Apraclonidine—glaucoma	0.000639	0.00245	CcSEcCtD
Nateglinide—Malnutrition—Betaxolol—glaucoma	0.000637	0.00245	CcSEcCtD
Nateglinide—Urticaria—Dorzolamide—glaucoma	0.000629	0.00242	CcSEcCtD
Nateglinide—Abdominal pain—Dorzolamide—glaucoma	0.000626	0.0024	CcSEcCtD
Nateglinide—Abdominal pain—Travoprost—glaucoma	0.000623	0.00239	CcSEcCtD
Nateglinide—Asthenia—Acetazolamide—glaucoma	0.00062	0.00238	CcSEcCtD
Nateglinide—Dizziness—Bimatoprost—glaucoma	0.000619	0.00238	CcSEcCtD
Nateglinide—Urticaria—Brinzolamide—glaucoma	0.000618	0.00237	CcSEcCtD
Nateglinide—Vomiting—Apraclonidine—glaucoma	0.000614	0.00236	CcSEcCtD
Nateglinide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000612	0.00235	CcSEcCtD
Nateglinide—Hypersensitivity—Brimonidine—glaucoma	0.000611	0.00235	CcSEcCtD
Nateglinide—Dermatitis—Apraclonidine—glaucoma	0.000608	0.00234	CcSEcCtD
Nateglinide—Tremor—Betaxolol—glaucoma	0.000597	0.00229	CcSEcCtD
Nateglinide—Asthenia—Brimonidine—glaucoma	0.000595	0.00228	CcSEcCtD
Nateglinide—Abdominal pain—Pilocarpine—glaucoma	0.000592	0.00227	CcSEcCtD
Nateglinide—Diarrhoea—Acetazolamide—glaucoma	0.000591	0.00227	CcSEcCtD
Nateglinide—Rash—Bimatoprost—glaucoma	0.00059	0.00227	CcSEcCtD
Nateglinide—Dermatitis—Bimatoprost—glaucoma	0.00059	0.00226	CcSEcCtD
Nateglinide—Oedema peripheral—Timolol—glaucoma	0.000589	0.00226	CcSEcCtD
Nateglinide—Pruritus—Brimonidine—glaucoma	0.000587	0.00225	CcSEcCtD
Nateglinide—Hypersensitivity—Dorzolamide—glaucoma	0.000583	0.00224	CcSEcCtD
Nateglinide—Hypersensitivity—Travoprost—glaucoma	0.000581	0.00223	CcSEcCtD
Nateglinide—Hyperhidrosis—Clonidine—glaucoma	0.000578	0.00222	CcSEcCtD
Nateglinide—Nausea—Apraclonidine—glaucoma	0.000574	0.0022	CcSEcCtD
Nateglinide—Hypersensitivity—Brinzolamide—glaucoma	0.000574	0.0022	CcSEcCtD
Nateglinide—Dizziness—Acetazolamide—glaucoma	0.000571	0.00219	CcSEcCtD
Nateglinide—Asthenia—Dorzolamide—glaucoma	0.000568	0.00218	CcSEcCtD
Nateglinide—Asthenia—Travoprost—glaucoma	0.000566	0.00217	CcSEcCtD
Nateglinide—Palpitations—Betaxolol—glaucoma	0.000563	0.00216	CcSEcCtD
Nateglinide—Pruritus—Dorzolamide—glaucoma	0.00056	0.00215	CcSEcCtD
Nateglinide—Asthenia—Brinzolamide—glaucoma	0.000559	0.00214	CcSEcCtD
Nateglinide—Pruritus—Travoprost—glaucoma	0.000558	0.00214	CcSEcCtD
Nateglinide—Cough—Betaxolol—glaucoma	0.000556	0.00214	CcSEcCtD
Nateglinide—Nausea—Bimatoprost—glaucoma	0.000556	0.00214	CcSEcCtD
Nateglinide—Hypersensitivity—Pilocarpine—glaucoma	0.000551	0.00212	CcSEcCtD
Nateglinide—Pruritus—Brinzolamide—glaucoma	0.000551	0.00211	CcSEcCtD
Nateglinide—Vomiting—Acetazolamide—glaucoma	0.000549	0.00211	CcSEcCtD
Nateglinide—Dizziness—Brimonidine—glaucoma	0.000548	0.00211	CcSEcCtD
Nateglinide—Diarrhoea—Dorzolamide—glaucoma	0.000542	0.00208	CcSEcCtD
Nateglinide—Immune system disorder—Timolol—glaucoma	0.00054	0.00207	CcSEcCtD
Nateglinide—Diarrhoea—Travoprost—glaucoma	0.000539	0.00207	CcSEcCtD
Nateglinide—Asthenia—Pilocarpine—glaucoma	0.000537	0.00206	CcSEcCtD
Nateglinide—Diarrhoea—Brinzolamide—glaucoma	0.000533	0.00204	CcSEcCtD
Nateglinide—Pruritus—Pilocarpine—glaucoma	0.000529	0.00203	CcSEcCtD
Nateglinide—Dizziness—Dorzolamide—glaucoma	0.000524	0.00201	CcSEcCtD
Nateglinide—Rash—Brimonidine—glaucoma	0.000523	0.00201	CcSEcCtD
Nateglinide—Dermatitis—Brimonidine—glaucoma	0.000522	0.00201	CcSEcCtD
Nateglinide—Dizziness—Travoprost—glaucoma	0.000521	0.002	CcSEcCtD
Nateglinide—Malnutrition—Timolol—glaucoma	0.000521	0.002	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Clonidine—glaucoma	0.000516	0.00198	CcSEcCtD
Nateglinide—Fatigue—Clonidine—glaucoma	0.000515	0.00198	CcSEcCtD
Nateglinide—Dizziness—Brinzolamide—glaucoma	0.000515	0.00198	CcSEcCtD
Nateglinide—Nausea—Acetazolamide—glaucoma	0.000513	0.00197	CcSEcCtD
Nateglinide—Diarrhoea—Pilocarpine—glaucoma	0.000512	0.00197	CcSEcCtD
Nateglinide—Vomiting—Dorzolamide—glaucoma	0.000503	0.00193	CcSEcCtD
Nateglinide—Hyperhidrosis—Betaxolol—glaucoma	0.000503	0.00193	CcSEcCtD
Nateglinide—Rash—Dorzolamide—glaucoma	0.000499	0.00192	CcSEcCtD
Nateglinide—Dermatitis—Dorzolamide—glaucoma	0.000499	0.00192	CcSEcCtD
Nateglinide—Rash—Travoprost—glaucoma	0.000497	0.00191	CcSEcCtD
Nateglinide—Dermatitis—Travoprost—glaucoma	0.000497	0.00191	CcSEcCtD
Nateglinide—Vomiting—Brinzolamide—glaucoma	0.000495	0.0019	CcSEcCtD
Nateglinide—Dizziness—Pilocarpine—glaucoma	0.000495	0.0019	CcSEcCtD
Nateglinide—Nausea—Brimonidine—glaucoma	0.000493	0.00189	CcSEcCtD
Nateglinide—Rash—Brinzolamide—glaucoma	0.000491	0.00188	CcSEcCtD
Nateglinide—Dermatitis—Brinzolamide—glaucoma	0.00049	0.00188	CcSEcCtD
Nateglinide—Gastrointestinal pain—Clonidine—glaucoma	0.000489	0.00188	CcSEcCtD
Nateglinide—Vomiting—Pilocarpine—glaucoma	0.000476	0.00183	CcSEcCtD
Nateglinide—Urticaria—Clonidine—glaucoma	0.000475	0.00182	CcSEcCtD
Nateglinide—Abdominal pain—Clonidine—glaucoma	0.000472	0.00181	CcSEcCtD
Nateglinide—Rash—Pilocarpine—glaucoma	0.000472	0.00181	CcSEcCtD
Nateglinide—Dermatitis—Pilocarpine—glaucoma	0.000471	0.00181	CcSEcCtD
Nateglinide—Nausea—Dorzolamide—glaucoma	0.00047	0.00181	CcSEcCtD
Nateglinide—Nausea—Travoprost—glaucoma	0.000468	0.0018	CcSEcCtD
Nateglinide—Nausea—Brinzolamide—glaucoma	0.000462	0.00178	CcSEcCtD
Nateglinide—Palpitations—Timolol—glaucoma	0.00046	0.00177	CcSEcCtD
Nateglinide—Dyspepsia—Betaxolol—glaucoma	0.000458	0.00176	CcSEcCtD
Nateglinide—Cough—Timolol—glaucoma	0.000454	0.00174	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000449	0.00172	CcSEcCtD
Nateglinide—Fatigue—Betaxolol—glaucoma	0.000449	0.00172	CcSEcCtD
Nateglinide—Nausea—Pilocarpine—glaucoma	0.000444	0.00171	CcSEcCtD
Nateglinide—Hypersensitivity—Clonidine—glaucoma	0.00044	0.00169	CcSEcCtD
Nateglinide—Asthenia—Clonidine—glaucoma	0.000429	0.00165	CcSEcCtD
Nateglinide—Pruritus—Clonidine—glaucoma	0.000423	0.00162	CcSEcCtD
Nateglinide—Urticaria—Betaxolol—glaucoma	0.000413	0.00159	CcSEcCtD
Nateglinide—Hyperhidrosis—Timolol—glaucoma	0.000411	0.00158	CcSEcCtD
Nateglinide—Diarrhoea—Clonidine—glaucoma	0.000409	0.00157	CcSEcCtD
Nateglinide—Dizziness—Clonidine—glaucoma	0.000395	0.00152	CcSEcCtD
Nateglinide—Hypersensitivity—Betaxolol—glaucoma	0.000383	0.00147	CcSEcCtD
Nateglinide—Vomiting—Clonidine—glaucoma	0.00038	0.00146	CcSEcCtD
Nateglinide—Rash—Clonidine—glaucoma	0.000377	0.00145	CcSEcCtD
Nateglinide—Dermatitis—Clonidine—glaucoma	0.000376	0.00145	CcSEcCtD
Nateglinide—Dyspepsia—Timolol—glaucoma	0.000374	0.00144	CcSEcCtD
Nateglinide—Asthenia—Betaxolol—glaucoma	0.000373	0.00143	CcSEcCtD
Nateglinide—Pruritus—Betaxolol—glaucoma	0.000368	0.00141	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Timolol—glaucoma	0.000367	0.00141	CcSEcCtD
Nateglinide—Fatigue—Timolol—glaucoma	0.000366	0.00141	CcSEcCtD
Nateglinide—Diarrhoea—Betaxolol—glaucoma	0.000356	0.00137	CcSEcCtD
Nateglinide—Nausea—Clonidine—glaucoma	0.000355	0.00136	CcSEcCtD
Nateglinide—Gastrointestinal pain—Timolol—glaucoma	0.000348	0.00133	CcSEcCtD
Nateglinide—Dizziness—Betaxolol—glaucoma	0.000344	0.00132	CcSEcCtD
Nateglinide—Urticaria—Timolol—glaucoma	0.000338	0.0013	CcSEcCtD
Nateglinide—Abdominal pain—Timolol—glaucoma	0.000336	0.00129	CcSEcCtD
Nateglinide—Vomiting—Betaxolol—glaucoma	0.000331	0.00127	CcSEcCtD
Nateglinide—Rash—Betaxolol—glaucoma	0.000328	0.00126	CcSEcCtD
Nateglinide—Dermatitis—Betaxolol—glaucoma	0.000328	0.00126	CcSEcCtD
Nateglinide—Hypersensitivity—Timolol—glaucoma	0.000313	0.0012	CcSEcCtD
Nateglinide—Nausea—Betaxolol—glaucoma	0.000309	0.00119	CcSEcCtD
Nateglinide—Asthenia—Timolol—glaucoma	0.000305	0.00117	CcSEcCtD
Nateglinide—Pruritus—Timolol—glaucoma	0.000301	0.00115	CcSEcCtD
Nateglinide—Diarrhoea—Timolol—glaucoma	0.000291	0.00112	CcSEcCtD
Nateglinide—Dizziness—Timolol—glaucoma	0.000281	0.00108	CcSEcCtD
Nateglinide—Vomiting—Timolol—glaucoma	0.00027	0.00104	CcSEcCtD
Nateglinide—Rash—Timolol—glaucoma	0.000268	0.00103	CcSEcCtD
Nateglinide—Dermatitis—Timolol—glaucoma	0.000268	0.00103	CcSEcCtD
Nateglinide—Nausea—Timolol—glaucoma	0.000252	0.000969	CcSEcCtD
Nateglinide—CYP2D6—Biological oxidations—GSTT1—glaucoma	8.68e-05	0.00106	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTT1—glaucoma	8.61e-05	0.00105	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CA5A—glaucoma	8.56e-05	0.00104	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NARFL—glaucoma	8.56e-05	0.00104	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.52e-05	0.00104	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.49e-05	0.00103	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	8.31e-05	0.00101	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	8.07e-05	0.000983	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CA1—glaucoma	8e-05	0.000975	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.83e-05	0.000954	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—GSTM1—glaucoma	7.78e-05	0.000948	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CTSA—glaucoma	7.75e-05	0.000944	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	7.67e-05	0.000935	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CA5A—glaucoma	7.37e-05	0.000898	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NARFL—glaucoma	7.37e-05	0.000898	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CA2—glaucoma	7.32e-05	0.000892	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TXN—glaucoma	7.19e-05	0.000877	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—CDKN2B—glaucoma	7.17e-05	0.000874	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.15e-05	0.000872	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.15e-05	0.000872	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—MMP1—glaucoma	7.12e-05	0.000868	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TNF—glaucoma	7.09e-05	0.000864	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TXN—glaucoma	6.98e-05	0.00085	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SOD1—glaucoma	6.96e-05	0.000848	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	6.92e-05	0.000843	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TXN—glaucoma	6.88e-05	0.000838	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CA1—glaucoma	6.88e-05	0.000838	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	6.86e-05	0.000836	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—CAV1—glaucoma	6.83e-05	0.000832	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	6.82e-05	0.000832	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	6.79e-05	0.000827	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	6.77e-05	0.000824	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—TNF—glaucoma	6.74e-05	0.000822	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CTSA—glaucoma	6.66e-05	0.000811	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—FN1—glaucoma	6.5e-05	0.000792	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	6.46e-05	0.000787	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.41e-05	0.000781	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NR3C1—glaucoma	6.29e-05	0.000767	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CA2—glaucoma	6.29e-05	0.000766	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.15e-05	0.000749	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.15e-05	0.000749	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	6.11e-05	0.000745	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NARFL—glaucoma	6.09e-05	0.000742	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CA5A—glaucoma	6.09e-05	0.000742	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NARFL—glaucoma	6.03e-05	0.000735	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CA5A—glaucoma	6.03e-05	0.000735	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.03e-05	0.000735	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CA1—glaucoma	5.78e-05	0.000705	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.68e-05	0.000692	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CA1—glaucoma	5.61e-05	0.000683	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CTSA—glaucoma	5.6e-05	0.000682	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTT1—glaucoma	5.58e-05	0.00068	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—GSTM1—glaucoma	5.53e-05	0.000674	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—glaucoma	5.49e-05	0.000669	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TNF—glaucoma	5.49e-05	0.000669	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.48e-05	0.000668	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	5.46e-05	0.000665	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CTSA—glaucoma	5.43e-05	0.000662	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTT1—glaucoma	5.41e-05	0.000659	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.41e-05	0.000659	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	5.38e-05	0.000656	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTT1—glaucoma	5.33e-05	0.00065	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—MMP1—glaucoma	5.31e-05	0.000647	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CA2—glaucoma	5.29e-05	0.000645	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	5.23e-05	0.000637	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NOS3—glaucoma	5.16e-05	0.000629	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TXN—glaucoma	5.16e-05	0.000628	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CA2—glaucoma	5.13e-05	0.000625	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—CAV1—glaucoma	5.09e-05	0.00062	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.01e-05	0.000611	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.01e-05	0.000611	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—FN1—glaucoma	4.85e-05	0.00059	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—glaucoma	4.84e-05	0.000589	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.7e-05	0.000573	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.66e-05	0.000568	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.52e-05	0.000551	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.46e-05	0.000544	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP1B1—glaucoma	4.45e-05	0.000542	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ABCA1—glaucoma	4.45e-05	0.000542	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TXN—glaucoma	4.43e-05	0.00054	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.41e-05	0.000538	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—glaucoma	4.41e-05	0.000538	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—TNF—glaucoma	4.36e-05	0.000531	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ABCA1—glaucoma	4.31e-05	0.000525	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP1B1—glaucoma	4.31e-05	0.000525	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	4.25e-05	0.000518	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP1B1—glaucoma	4.25e-05	0.000518	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ABCA1—glaucoma	4.25e-05	0.000518	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP2—glaucoma	4.21e-05	0.000513	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CA1—glaucoma	4.18e-05	0.000509	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB2—glaucoma	4.16e-05	0.000507	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CTSA—glaucoma	4.05e-05	0.000493	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.04e-05	0.000493	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.01e-05	0.000488	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTT1—glaucoma	4e-05	0.000487	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NARFL—glaucoma	3.98e-05	0.000485	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA5A—glaucoma	3.98e-05	0.000485	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NOS3—glaucoma	3.85e-05	0.000469	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CA2—glaucoma	3.82e-05	0.000466	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TXN—glaucoma	3.73e-05	0.000454	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—glaucoma	3.72e-05	0.000453	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.62e-05	0.000441	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TXN—glaucoma	3.61e-05	0.00044	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CA1—glaucoma	3.6e-05	0.000439	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.57e-05	0.000435	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTM1—glaucoma	3.55e-05	0.000433	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CTSA—glaucoma	3.49e-05	0.000425	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—CDKN2B—glaucoma	3.45e-05	0.000421	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTM1—glaucoma	3.45e-05	0.00042	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTT1—glaucoma	3.44e-05	0.000419	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTM1—glaucoma	3.4e-05	0.000414	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.3e-05	0.000402	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CA2—glaucoma	3.29e-05	0.000401	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.27e-05	0.000398	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.22e-05	0.000393	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.22e-05	0.000392	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.22e-05	0.000392	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP1B1—glaucoma	3.19e-05	0.000388	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ABCA1—glaucoma	3.19e-05	0.000388	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—glaucoma	3.17e-05	0.000386	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SOD1—glaucoma	3.15e-05	0.000384	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—MTHFR—glaucoma	3.14e-05	0.000383	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—MTHFR—glaucoma	3.05e-05	0.000371	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NR3C1—glaucoma	3.03e-05	0.000369	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—MTHFR—glaucoma	3e-05	0.000366	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CA1—glaucoma	2.97e-05	0.000362	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CA1—glaucoma	2.95e-05	0.000359	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—APOE—glaucoma	2.92e-05	0.000356	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CAV1—glaucoma	2.9e-05	0.000353	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTT1—glaucoma	2.89e-05	0.000352	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CTSA—glaucoma	2.88e-05	0.000351	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CTSA—glaucoma	2.85e-05	0.000348	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—glaucoma	2.84e-05	0.000346	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—APOE—glaucoma	2.84e-05	0.000345	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—glaucoma	2.81e-05	0.000342	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CAV1—glaucoma	2.81e-05	0.000342	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTT1—glaucoma	2.8e-05	0.000341	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—APOE—glaucoma	2.79e-05	0.00034	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—glaucoma	2.77e-05	0.000338	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.77e-05	0.000338	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CAV1—glaucoma	2.77e-05	0.000337	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ABCA1—glaucoma	2.74e-05	0.000334	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1B1—glaucoma	2.74e-05	0.000334	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CA2—glaucoma	2.72e-05	0.000331	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CA2—glaucoma	2.7e-05	0.000328	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TXN—glaucoma	2.69e-05	0.000328	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.63e-05	0.000321	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.63e-05	0.000321	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTM1—glaucoma	2.55e-05	0.00031	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—glaucoma	2.44e-05	0.000297	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.43e-05	0.000297	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MMP1—glaucoma	2.4e-05	0.000293	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TXN—glaucoma	2.32e-05	0.000283	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—CAV1—glaucoma	2.3e-05	0.000281	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ABCA1—glaucoma	2.3e-05	0.000281	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1B1—glaucoma	2.3e-05	0.000281	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.26e-05	0.000275	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTHFR—glaucoma	2.25e-05	0.000274	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ABCA1—glaucoma	2.23e-05	0.000272	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1B1—glaucoma	2.23e-05	0.000272	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—FN1—glaucoma	2.19e-05	0.000267	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NOS3—glaucoma	2.19e-05	0.000267	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTM1—glaucoma	2.19e-05	0.000267	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NOS3—glaucoma	2.12e-05	0.000259	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.12e-05	0.000258	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.1e-05	0.000256	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—glaucoma	2.1e-05	0.000255	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOE—glaucoma	2.1e-05	0.000255	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NOS3—glaucoma	2.09e-05	0.000255	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTT1—glaucoma	2.09e-05	0.000255	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CAV1—glaucoma	2.08e-05	0.000253	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—glaucoma	2e-05	0.000244	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA1—glaucoma	1.94e-05	0.000237	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—glaucoma	1.94e-05	0.000237	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—glaucoma	1.93e-05	0.000236	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TXN—glaucoma	1.92e-05	0.000233	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—glaucoma	1.91e-05	0.000233	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TXN—glaucoma	1.9e-05	0.000231	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CTSA—glaucoma	1.88e-05	0.000229	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—glaucoma	1.84e-05	0.000224	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—glaucoma	1.8e-05	0.000219	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTT1—glaucoma	1.8e-05	0.000219	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAV1—glaucoma	1.78e-05	0.000217	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—glaucoma	1.78e-05	0.000217	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA2—glaucoma	1.78e-05	0.000217	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS3—glaucoma	1.74e-05	0.000212	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.73e-05	0.000211	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.72e-05	0.000209	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCA1—glaucoma	1.66e-05	0.000203	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1B1—glaucoma	1.66e-05	0.000203	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—glaucoma	1.63e-05	0.000198	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—glaucoma	1.58e-05	0.000192	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NOS3—glaucoma	1.57e-05	0.000191	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—glaucoma	1.51e-05	0.000185	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAV1—glaucoma	1.5e-05	0.000183	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—glaucoma	1.49e-05	0.000181	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—glaucoma	1.47e-05	0.000179	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—glaucoma	1.47e-05	0.000179	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAV1—glaucoma	1.45e-05	0.000177	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.45e-05	0.000177	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—glaucoma	1.44e-05	0.000175	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCA1—glaucoma	1.43e-05	0.000175	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1B1—glaucoma	1.43e-05	0.000175	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—glaucoma	1.35e-05	0.000164	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—glaucoma	1.33e-05	0.000162	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—glaucoma	1.25e-05	0.000153	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TXN—glaucoma	1.25e-05	0.000153	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—glaucoma	1.23e-05	0.00015	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.19e-05	0.000145	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1B1—glaucoma	1.18e-05	0.000144	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCA1—glaucoma	1.18e-05	0.000144	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—glaucoma	1.18e-05	0.000143	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCA1—glaucoma	1.17e-05	0.000143	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1B1—glaucoma	1.17e-05	0.000143	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—glaucoma	1.15e-05	0.00014	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—glaucoma	1.13e-05	0.000138	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—glaucoma	1.1e-05	0.000134	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—glaucoma	1.09e-05	0.000133	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—glaucoma	1.08e-05	0.000132	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—glaucoma	1.04e-05	0.000126	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—glaucoma	1.01e-05	0.000123	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—glaucoma	1.01e-05	0.000123	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—glaucoma	9.71e-06	0.000118	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—glaucoma	9.48e-06	0.000116	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—glaucoma	9.46e-06	0.000115	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—glaucoma	9.43e-06	0.000115	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—glaucoma	9.38e-06	0.000114	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—glaucoma	9.34e-06	0.000114	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—glaucoma	8.36e-06	0.000102	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—glaucoma	8.29e-06	0.000101	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—glaucoma	8.2e-06	9.99e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—glaucoma	7.78e-06	9.48e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCA1—glaucoma	7.74e-06	9.43e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1B1—glaucoma	7.74e-06	9.43e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—glaucoma	7.72e-06	9.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—glaucoma	7.71e-06	9.4e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—glaucoma	7.65e-06	9.32e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—glaucoma	7.5e-06	9.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—glaucoma	7.06e-06	8.61e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—glaucoma	6.46e-06	7.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—glaucoma	6.19e-06	7.54e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—glaucoma	5.83e-06	7.11e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—glaucoma	5.78e-06	7.04e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—glaucoma	5.47e-06	6.66e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—glaucoma	5.33e-06	6.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—glaucoma	5.29e-06	6.44e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—glaucoma	5.09e-06	6.2e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—glaucoma	5.04e-06	6.14e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—glaucoma	3.81e-06	4.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—glaucoma	3.49e-06	4.25e-05	CbGpPWpGaD
